Icahn School of Medicine at Mount Sinai

Program

A full day of discussion on drug target discovery, validation, and repurposing.

Sessions

Session times will be announced here.

  1. Opening

    Welcome and opening remarks

    The two departments will open the symposium and frame the questions that connect the day’s sessions, from choosing targets to deciding what evidence would support developing a therapy.

  2. Keynote

    Keynote address

    An invited talk on how AI and human genetics can inform therapeutic discovery, and how researchers can judge which predictions are worth pursuing.

  3. Trainee discussion30 minutes

    Keynote discussion

    A separate, informal Q&A for trainees to talk with the keynote speaker about the role of AI in biomedical research.

  4. Panel 1

    The Inside Track

    Drug discovery resources at Mount Sinai

    What support is available to researchers moving a genetic finding toward drug discovery? This panel will discuss Mount Sinai resources, the kinds of projects they can help with, and how researchers can begin working with them.

  5. Panel 2

    Show Me the Variant

    Identifying drug targets

    How do researchers decide which genetic findings point to targets worth testing? This panel will look at what the Genetic Priority Score and other tools can tell researchers about a potential target, how AI can help interpret the evidence, and when more evidence is needed.

  6. Panel 3

    The Burden of Proof

    Choosing models and experiments

    What makes an experiment a good test of a predicted drug target? Panelists will discuss how to choose models and assays, interpret results across systems, and judge when the evidence supports taking a target further.

  7. Panel 4

    The Second Indication

    Drug repurposing

    When might an existing medicine be useful for a different disease? This panel will examine how genetic evidence and pharmacology can suggest new uses and what researchers would need to test before pursuing them.

  8. Project pitches

    From Pitch to Pilot

    In this Shark Tank-style session, finalist teams will pitch early drug discovery projects to a panel. The panel will provide feedback and award pilot funding to the teams with the most potential to move their projects forward.

    Explore the pitch session